2-Methyl-2H-pyrazol-3-ylamine → HCID 57497053, compound
Reaction equation
C(OC(=O)[NH:7][C:8]1[N:9]([CH3:26])[C:10](=[O:25])[C:11]([CH3:24])([CH3:23])[C@:12]([C:15]2[CH:20]=[C:19](Br)[CH:18]=[CH:17][C:16]=2[F:22])([CH3:14])[N:13]=1)(C)(C)C.[CH3:28][N:29]1[C:33]([NH2:34])=[CH:32][CH:31]=[N:30]1>>[NH2:7][C:8]1[N:9]([CH3:26])[C:10](=[O:25])[C:11]([CH3:24])([CH3:23])[C@:12]([C:15]2[CH:20]=[C:19]([NH:34][C:33]3[N:29]([CH3:28])[N:30]=[CH:31][CH:32]=3)[CH:18]=[CH:17][C:16]=2[F:22])([CH3:14])[N:13]=1Participants
3
Procedure
The coupling of [(S)-4-(5-bromo-2-fluoro-phenyl)-1,4,5,5-tetramethyl-6-oxo-1,4,5,6-tetrahydro-pyrimidin-2-yl]-carbamic acid tert-butyl ester (intermediate E8) and 2-methyl-2H-pyrazol-3-ylamine according to procedure B followed by deprotection yielded the title compound as a pale brown waxy solid. MS (ESI): m/z=359.2 [M+H]+.
Sources & evidence
- ORD record
- ord-d4780feec8a9475083afa2f2d841b869
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08815881B2
Reaction notes
Loading…